Lulu E. Yan

Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells

Yupo Ma, J. C. Petrov, X. Shuai, 2019, Journal of Cancer.

Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia

Yupo Ma, Lai-han Leung, J. C. Petrov, 2018, Leukemia.

High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.

Daohai Yu, M. Iannacone, C. Cogle, 2014, Leukemia research.

Erlotinib for Treatment of Myelodysplastic Syndromes: A Phase II Clinical Study

Daohai Yu, J. Lancet, Ling Zhang, 2010 .

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Daohai Yu, J. Weber, M. Yellin, 2010, Clinical Cancer Research.

Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy

Yupo Ma, W. Tse, Hongyu Zhang, 2020, Stem Cell Reviews and Reports.

A compound chimeric antigen receptor strategy for targeting multiple myeloma

J. C. Petrov, X. Shuai, K. H. Chen, 2017, Leukemia.